baber/WOPTO huggingface dataset:
Patent PT-1079939-E (PT)
Inventor: WERDINIG HELMUT
IPC: B07B13/04
Filed: 1999-05-11
Abstract: A separating device for elongate solid pieces includes a vibrating base with longitudinal grooves having a depth which decreases in a conveying direction, to allow efficient separation of elongate solid pieces, in particular of short pieces of wire, and to allow the separating device to operate continuously. The longitudinal grooves are adjoined by elongate, e.g. V-shaped, screen openings for separating the elongate solid pieces. Wide solid pieces can slide over the screen openings. The separating device is suitable in particular for separating small pieces of wire out of pyrolysis residue from a pyrolysis plant.
Patent PT-1137792-E (PT)
Title: A recombinant vector expressing multiple costimulatory molecules and uses thereof
Inventor: SCHLOM JEFFREY
IPC: A61K35/12
Filed: 1999-11-12
Abstract: The present invention is a recombinant vector encoding and expressing at least three or more costimulatory molecules. The recombinant vector may additionally contain a gene encoding one or more target antigens or immunological epitope thereof. The synergistic effect of these costimulatory molecules on the enhanced activation of T cells is demonstrated. The degree of T-cell activation using recombinant vectors containing genes encoding three costimulatory molecules was far greater than the sum of recombinant vector constructs containing one costimulatory molecule and greater than the use of two costimulatory molecules. Results employing the triple costimulatory vectors were most dramatic under conditions of either low levels of first signal or low stimulator to T-cell ratios. This phenomenon was observed with both isolated CD4<+> and CD8<+> T cells. The recombinant vectors of the present invention are useful as immunogenes and vaccines against cancer and pathogenic micro-organisms, and in providing host cells, including dendritic cells and splenocytes with enhanced antigen-presenting functions.
Patent IE-37470-L (IE)
Title: Drying moulded gypsum articles
IPC: F26B23/10
Filed: 1973-03-13
Abstract: 1418935 Drying moulded articles GIULINI GmbH Gebr 16 March 1973 [17 March 1972] 12843/73 Heading F4G A process for drying a moulded gypsum article 5 in sheet form comprises drying the article in contact with, or by radiant heat from, a heated surface held at a temperature of 50-170 C. The apparatus used by the process may have a number of heating surfaces 6 between which a number of articles 5 to be dried can be interposed, means for heating the surfaces, and means for moving the heating surfaces from one heat supply point to another or for moving articles after drying away from the heating surfaces. A conveyer may be provided for moving the articles away from the heating surfaces. At least two sets of heating surfaces may be provided so that the articles may be first subjected to heat at one temperature and then subjected to heat at a lower temperature. The heating surfaces may be planar. The temperature of the heated surface or surfaces may be 90 to 160 C., and may be continuously reduced or reduced stepwise during the drying process.
[GB1418935A]
Patent IE-820665-L (IE)
Title: Guanidinopyrimidines
IPC: C07D239/50
Filed: 1982-03-23
Abstract: 2,4-Amino, guanidinopyrimidines have diuretic activity. A representative species of these compounds is 2-guanidino-4-amino-6-chloroguanidine which is prepared by the stepwise replacement of first the 2-halo of a 2,4,6-trihalopyrimidine by guanidino and then the 4-halo by ammonia.
Patent IE-870734-L (IE)
Title: Purification of tetraacetylethylene diamine.
IPC: C07C229/06
Filed: 1987-03-20
Abstract: Crude tetraacetylethylenediamine (TAED), such as obtained in crystalline form during synthesis, is converted by successive washing with acetic acid and water and subsequent drying into a colourless and odourless form, such as is required for use in detergents and bleaching agents.
Patent FI-803402-L (FI)
Inventor: RIPKENS GERD
IPC: C08L97/02
Filed: 1980-10-30
Abstract: A process for the manufacture of triple- and multi-layer particle board employing phenol formaldehyde resin compositions for gluing particles in the outer layers of the board characterized by the use of a phenol formaldehyde resin composition having a viscosity of about 30-90 seconds (4-mm DIN cup), a solids content of between about 30 and 39 percent by weight and an alkali content of less than 8 percent by weight is provided.
Patent FI-831920-L (FI)
Inventor: BAYER HORST OTTO
IPC: A61K31/41
Filed: 1983-05-30
Abstract: Biocidal or biostatic compositions containing one or more of a specified range of 3-isothiazolone(s), especially 5-chloro-2-methyl-4-isothiazolin-3-one and/or 2-methyl-4-isothiazolin-3-one, more especially a mixture of the two containing 60-90 weight percent of the chloro compound, having an impurity content (if any) of nitrosamine(s) plus nitrosamine precursor(s) less than 15 ppm, preferably 7.5 ppm, more preferably 3 ppm (on a weight basis) of the 3-isothiazolone(s) and nitrosating agent(s), such as nitrate salt ringstabiliser(s) capable of converting the precursor(s) to nitrosamine(s). The compositions can be made by processes involving purification of intermediate product(s) by ion exchange, recrystallization and/or solvent extraction and/or involving the use of nucleophilic scavenger(s) in the preparation of intermediate product(s) and/or involving the use of certain mercapto-amide(s) as intermediate products. Cosmetic (including toiletry) and pharmaceutical preparations containing the compositions are also disclosed.
Patent IE-891135-L (IE)
Title: Tetralin Esters of Phenols or Benzoic Acids Having Retinoid Like Activity
IPC: C07C69/773
Filed: 1989-04-10
Abstract: Retinoid-like activity is exhibited by compounds of the formula <CHEM> where the R groups are independently hydrogen, or lower alkyl; A is -C(O)O-, -OC(O)-, -C(O)S-, or -SC(O)-; n is 0-5; and Z is H, -COB where B is -OH or a pharmaceutically acceptable salt, or B is -OR1 where R1 is an ester-forming group, or B is -N(R)2 where R is hydrogen or lower alkyl, or Z is -OE where E is hydrogen or an ether-forming group or -COR2 where R2 is hydrogen, lower alkyl, phenyl or lower alkyl phenyl, or Z is -CHO or an acetal derivative thereof, or Z is -COR3 where R3 is -(CH2)mCH3 where m is 0-4 and the sum of n and m does not exceed 4.
[EP0337689A1]
Patent IE-781167-L (IE)
Title: Ó-halomethyl amino acids.
IPC: C07C239/00
Filed: 1978-06-08
Abstract: Novel pharmaceutically useful compounds of the formula <IMAGE> and pharmaceutically acceptable salts and individual optical isomers thereof, wherein Y is -CH2F, -CHF2, -CH2Cl or -CHCl2; R1 is hydrogen, (C1-4alkyl)carbonyl, (C1-4alkoxy)carbonyl or -CO-CHNH2-R27 wherein R27 is hydrogen, alkyl of 1 to 4 carbon atoms, benzyl or p-hydroxybenzyl; R is hydroxy, alkoxy of 1 to 8 carbon atoms, -NR7R8 wherein R7 and R8 are the same or different and are each hydrogen or alkyl of 1 to 4 carbon atoms or -NH-CHR9-COOH wherein R9 is hydrogen, alkyl of 1 to 4 carbon atoms, benzyl or p- hydroxybenzyl; and R2, R3, R4, R5 and R6 are various combinations of hydrogen, methyl, ethyl, tert-butyl, halogen, trifluoromethyl and OR10 wherein R10 is hydrogen, alkyl of 1 to 8 carbon atoms, (C1-6alkyl)carbonyl, benzoyl or phenyl (C1-6alkyl)-carbonyl or R3 and R4 together are methylenedioxy.
[GB2005659A]
Patent IE-39463-L (IE)
Title: Scallop spreading machine.
IPC: A22C29/04
Filed: 1974-06-04
Abstract: A scallop spreading machine is provided on a scallop eviscerator having rollers mounted on an eviscerator frame in an inclined path. The spreading machine includes a number of support frames extending across the inclined path of the eviscerator frame at spaced locations. A plurality of spreader fans, each including a plurality of radially extending blades having flexible wiping elements are mounted on each support in side-by-side relationship. Drive means are provided to rotate the spreader fans in a plane aligned with the inclined path. Adjustment means are provided to vary the height of the spreader fans above the eviscerator rolls. As they rotate, the wiping elements break up the clumps or piles of scallops which tend to form and distribute the scallops evenly on the rollers to position them so as to be subjected to the action of the eviscerator. The spreader fans also force the scallops back up the inclined path to lengthen the time the scallops are subjected to the action of the eviscerator. The height adjustment permits the spreader fans to be adjusted according to the size of the particular scallop batch being processed.
[US3864788A]
Patent IE-33305-L (IE)
Title: A water sampling device
IPC: G01N1/12
Filed: 1969-08-28
Abstract: 1,270,140. Sampling liquids. J. E. JOHANSSON. 29 Aug., 1969 [2 Sept., 1968], No. 43126/69. Heading B8N. A device for sampling water, e.g. in a lake or river comprises a cylinder 10 housing a movable piston 11, a rod 13 attached to the piston and extending through an end cap 19, and a valve comprised by the surface 27 of an annular member 25 and a plate 28. The annular member 25 and plate 28 are slidably retained by a member 33 pivotally connected to an annular member 23. A thermometer 15 is provided within the piston-rod 13 and extends into the chamber above the piston. Ribs 38, 39 secured to the rod 13 extend (as shown) through end cap 19 to the points 40 below the piston. In use with the valve closed, and the annular members 23, 25 abutting, the piston is moved to create a subatmospheric pressure in the chamber and is locked in its lowermost position by the ends 40 of the ribs, upon rotation of the rod through 90 degrees abutting the lower surface of the end cap 19. The cylinder is then lowered on a line 32 to a required depth. The valve is opened by jerking the line, thus allowing water to flow into the chamber via aperture 26. The cylinder is then pulled to the surface.
[GB1270140A]
Patent IE-871526-L (IE)
Title: Dihydrocodeine composition
IPC: A61K9/22
Filed: 1987-06-09
Abstract: A solid controlled release, oral dosage form, the dosage form comprising an analgesically effective amount of dihydrocodeine or a salt thereof in a controlled release matrix wherein the dissolution rate in vitro of the dosage form, when measured by the USP Paddle Method at 100 rpm in 900 ml aqueous buffer (pH between 1.6 and 7.2) at 37 DEG C is between 25% and 60% (by weight) dihydrocodeine released after 1 hour, between 45% and 80% (by weight) dihydrocodeine released after 2 hours, between 60% and 90% (by weight) dihydrocodeine released after 3 hours and between 70% and 100% (by weight) dihydrocodeine released after 4 hours, the in vitro release rate being independent of pH between pH 1.6 and 7.2 and chosen such that the peak plasma level of dihydrocodeine obtained in vivo occurs between 2 and 4 hours after administration of the dosage form.
Patent IE-791576-L (IE)
Title: Immunologic determinations
IPC: G01N33/58
Filed: 1979-08-16
Abstract: What is disclosed is a method for the immunological determination of an immuno-complex, comprising an antigen and an antibody, in a liquid containing said immuno-complex, which method comprises (a) incubating said liquid containing said immumo-complex with a first reagent bound to a carrier, said first reagent being specific for an antigenic determinant of the antigen in said immuno-complex and being present in an amount sufficient to fix said immuno-complex; (b) separating the carrier from said liquid containing said immuno-complex and incubating it in a solution of a second reagent, said second reagent being specific for an antigenic determinant of the antibody in said immuno-complex and being present in an amount sufficient to fix said immuno-complex; and (c) separating the carrier from said solution of the second reagent and determining the amount of bound or unbound second reagent.
Patent IE-37209-L (IE)
Title: 3-oxyiminomethyl cephalosporin compounds
IPC: C07D/
Filed: 1972-12-12
Abstract: Cpds. of formula (I): where n = 0 or 1 R=H, alkanoyl, (1-8C) chloro- or bromo-alkanoyl (2-8C) azidoacetyl cyanoacetyl, a gp (II): where Q = H, or methyl; Ar = 2- or 3-thienyl, 2- or 3-furyl, 2- or 3- pyrrolyl or phenyl opt. substd. with >=1 Cl, Br, I, F, CF3, hydroxy, alkyl, or alkoxy (1-3C) cyano or nitro, whereby >=1 of these substituents must be in m- or p-posn at the phenyl ring; Ar-X-CH2-C(O)-, where X = -O or -S; Ar = as signified or 4-pyridyl and X = -S; a gp. (III): Ar-C(X1)H-C(O)- where X1 = -NH2, -NH3 circled positive, amino protected by benzyloxycarbonyl, alkoxycarbonyl (1-4C) cyclopentoxycarbonyl, cyclohexoxy-carbonyl, benzhydryloxycarbonyl, triphenylmethyl, 2,2,2-trichloroethoxycarbonyl, a gp. (IV):- C(O)NH-C (=NH)-NH2 -SO3H, or phthalimido, the enamine form of methylacetylacetate or acetylacetone; or X1 = hydroxyl opt. protected by esterification with an alkanecarboxylic acid (1-6C) carboxyl, opt. protected by esterification with an alkanol (1-6C) or a gp, -N3, -CN or -C(O)NH2; or R = 2-sydnone-3-(C1-C3) alknoyl or a gp. (V): where m = 0,1 or 2; 5-aminodipoyl opt. amino-protected with alkanoyl (1-3C) or chloroalkanoyl (1-3C) or carboxyl-protected with benzyhydryl, 2,2,2-trichloroethyl, alkyl (4-6C) or nitrobenzyl; R1 = H, or R+R1+N = H3N- circled positive a salt gp. with an acid with a pK a-value of 4, or a cyclic imide derived from a dicarboxylic acid or a hydrocarbon (3-12C), a gp (VI); where Z = (-CH2-)y y = 1 or 2; or -O; or R+R1+N = (alkyl)2-N-CH=N- (alkyl 1-2C); R2 = tert. alkyl (4-6C) tert. alkenyl- or tert. alkynyl (5-7C) benzyl, methoxybenzyl, nitrobenzyl, 2,2,2-trichloroethyl, 3,5-di(t. butyl)4-hydroxybenzyl, acetoxymethyl, pivaloyloxymethyl, 2-iodoethyl, benzhydryl, phenacyl, trimethylsilyl, succinimidomethyl, phthalimidomethyl or H; Y = H, alkyl (1-6C), haloalkyl (2-6C) where halo = Cl or Br; aromatic hydrocarbon (6-12C) cycloalkyl (4-7C), alkylene-X-alkyl, where alkylene = 1-3C and X -O or -S; -CH2COOR3 where R3 = H or alkyl (1-6C), or -CH2CH2N(CH3)2. Pharmaceutically acceptable salts of (I) are included.
[FR2164793A1]
Patent IE-832078-L (IE)
Title: Removing nitrosating agents from aromatic nitro derivatives
IPC: C07C201/16
Filed: 1983-09-05
Abstract: 1. A process for removing nitrosating agents from aromatic nitro derivatives, characterized in that a crude product is treated which has been isolated after its fabrication and substantially made free from residual nitric acid originated from the nitration phase, consisting essentially of a compound of the general formula :  see diagramm : EP0105008,P5,F1  in which : - the symbols R, which are identical or different, represent a hydrogen or halogen atom, an alkyl radical containing from 1 to 4 carbon atoms or the trifluoromethyl, sulphonamido or methylsulphonyl group, and - m, n, p and q each represent an integer equal to 0 or 1, it also being possible for q to be equal to 2, with a base at the rate of 0.1 to 50 mol % relative to the crude aromatic nitro derivative, in solution in an inert organic solvent.
Patent IE-902149-L (IE)
Title: Syringe
IPC: A61M5/32
Filed: 1990-06-14
Abstract: The invention relates to an injection syringe (1) with a barrel (2) to whose one end an injection needle (11) can be attached, and with a piston (6) which is displaceable in the barrel (2) and to which a piston rod (5), projecting from the other end of the barrel (2) and provided at its end with an actuating handle (23), can be attached, characterised by a device (16, 20) for automatic locking of the piston (6), pushed forward over a predetermined distance towards the injection needle (11), against retraction of the piston (6). <IMAGE>
Patent IE-902272-L (IE)
Title: Compositions of 5-phenyl-2-furan ketones
IPC: A61K31/34
Filed: 1990-06-22
Abstract: A method of preventing epileptic seizures in a human or lower animal subject susceptible to said seizures, comprising systemically administering to said subject a safe and effective amount of a compound of the formula: <CHEM> wherein (a) X is halo or nil, and Y is a substituent selected from the group consisting of unsubstituted or halogen-substituted methyl, halo, nitro, amino, and methoxy; and (b) R is R<1>C(O)OH, R<1>C(O)N(R<2>)2, or R<1>N(R<2>)2; where R<1> is C1-C3 alkyl which is unsubstituted or substituted with C1-C2 alkyl; and each R<2> is, independently, hydrogen or lower alkyl; or both R<2> groups are connected to form a saturated 5- or 6-membered heterocycle containing 1 or 2 heteroatoms selected from oxygen and nitrogen and said heterocycle is unsubstituted or substituted with lower alkyl or hydroxy-substituted lower alkyl; or a pharmaceutically-acceptable salt thereof. Preferably X is halo.
[EP0404232A1]
Patent IE-842495-L (IE)
Title: Candle-shaped luminous body
IPC: F21S13/00
Filed: 1984-11-01
Abstract: The invention relates to a candle-shaped luminary, primarily intended for use in churches, chapels and other places of worship, which includes a cylindrical pipe, preferably made of a plastic material, with an outer jacket that is provided with a wax, stearin or imitation wax coating. A container of liquid fuel, preferably liquid wax or liquid paraffin, with a wick that extends from the upper side of the container through a wick-guiding tube, is mounted exchangeably inside the pipe. The exchangeable container is provided with an upper cover which corresponds to the width of the pipe, which abuts seamlessly against or on the upper edge of the pipe after the fuel is inserted, resulting in the exact image of the upper front area of a natural candle.
[US4567548A]
Patent IE-872799-L (IE)
Title: Peptide preparation
IPC: C07K14/62
Filed: 1987-10-19
Abstract: Insulin preparations with improved properties for parenteral administration can be prepared at pH values of about 3 to 8.5 by presence of magnesium ions in concentration of about 0,005 to 0.5 M.
[EP0265213A2]
Patent IE-883661-L (IE)
Title: Heterocyclic compounds
IPC: C07D209/30
Filed: 1988-12-08
Abstract: Heterocyclic urea and carbamate cpds. of formula A-X-NH-CW-Y-B (I) and pharmaceutically acceptable acid addn. salts are new where A is aromatic gp. of formula (A1)-(A4). R1 is H or one or more of lower alkyl, lower alkoxy, OH, halogen, lower haloalkyl, NH2, NO2, carboxamido, phenyl(lower) alkoxy (where phenyl is opt. substd. by lower alkyl, lower alkoxy or halogen substit(s).), acylamino or mono- or di-lower slkylamino, Z1-Z2 are CH2-CH, NR2-CH, 0-CH, -S-CH, CH2-N, O-N, S-N, NR2-N, CH-NR2 or N-NR2, R2 is H, lower alkyl or phenyl or phenyl(lower)alkyl where phenyl is opt. substd. by lower alkyl, lower alkoxy or halogen substit(s).; Z2-Z4 are CH:CH, O-CH2 or N:CH, Z5 is N or CH, Z6 is O, S or NH; X is a bond or -CO-, W is O or S, Y is NH or O, B is satd. azacyclic ring of formula (B1-(B5) or N-oxide of (B2), n is 2, 3 or 4, R3 is H or lower alkyl, m is 1, 2 or 3, p is 0, 1 or 2 and R4, R5 are H or lower alkyl, with the proviso that when X is bond, A is (A3) or (A4) and W is O, then (A3) or (A4) does not contain a substit. ortho to the -X-NH-Cw-Y-B side chain.
Patent NO-803929-L (NO)
Inventor: DICK GUENTER
IPC: F24S10/75
Filed: 1980-12-23
Abstract: 1. Heat exchanger placed on house roofs, house fronts, fences, and to similar locations, comprising a heat exchange sheet and at least one heat exchange channel, characterized by forming the heat exchange channel from a T-shaped extrusion profile (3), the face of which forms the contact plane, and further characterized by the said extrusion profile (3) being joined to the sheet by an elastic interlayer and affixed in the heat exchange sheet by means of a spring metal strip (4), the edges of which snap into the corrugations (2) of the heat exchange sheet.
Patent NO-810721-L (NO)
Title: Fremgangsmaate for fremstilling av n,n-dimetyl(aza-1-bicyklo(2,2,2)oktyl-3)-10-10h-fenotiazinsulfonamid-2
Inventor: RENAULT CHRISTIAN
IPC: C07D453/02
Filed: 1981-03-03
Abstract: N,N-dimetyl-[aza-l-bicyklo[2,2,2]oktyl-3]-10. 10H-fenotiazinsulfonamid-2 med formelen:. Denne forbindelse fremstilles ved ringslutning av N,N-dimetyl[(aza-l-bicyklo[2,2,2]oktyl-3)-amino]-3[(brom-2-fenyl)tio]-4-benzensulfonamid i nærvær av et alkalimetallamid.Den fremstilte forbindelse er virksom som inhibitor for mavesaftsekresjon.
Patent NO-823157-L (NO)
Inventor: ANGELLA FRANCO
IPC: B29D99/00
Filed: 1982-09-17
Abstract: Process for the netlike opening of fibrilled polymeric films, said process consisting in conveying to an opening device of the conventional type (based, for instance, on diverging transferring elements and on lateral film pulling elements such as clamps, grippers or pins, which engage the film at its edges and which are fixed on said traverse elements) the fibrilled film of an undulated or corrugated shape, with the front of the corrugations or waves perpendicular to the direction of the transferring motion, so that the length of the film between the lateral consecutive pulling elements be in excess with respect to the distance between said elements, wherefore said excess will compensate the longitudinal shrinkage that the film will suffer during the transversal opening.
Patent NO-840044-L (NO)
Inventor: DARBYSHIRE JOHN
IPC: C12G3/08
Filed: 1984-01-06
Abstract: A must is fermented with a combination of at least one yeast and at least one lactobacillus, the former being selected from the group of Saccharomyces cerevisiae and Kluyveromyces lactis and the latter being selected from the group of Lactobacillus casei and Lactobacillus hilgardii for their symbiotic ability and capability to produce a synergistic organoleptic effect which eliminates all after-taste of yeast. The must is inoculated such that the respective numbers of yeast germs and lactobacilli germs per ml have a ratio of from 1:10 to 1:500.
Patent NO-863772-L (NO)
Inventor: WEICKERT WALTER R
IPC: B41L47/46
Filed: 1986-09-23
Abstract: A motor operated imprinter is disclosed. The imprinter is easy to use as a consequence of the print bearing elements and formset being retained on a generally horizontally disposed surface. A head bearing a rolling platen is pivoted from an open position which exposes the surface for retaining the print bearing element and the formset to a closed position to activate the imprinting cycle. An uncomplicated mechanism is used for transmitting power from a motor located in the base to the head.
Patent NO-873248-L (NO)
Inventor: HERMECZ ISTVAN
IPC: C07D295/067
Filed: 1987-08-03
Abstract: The invention relates to a new process for the preparation of a compound of the Formula I <CHEM> wherein R stands for methyl and pharmaceutically acceptable salts thereof which comprises reacting a compound of the general Formula V <CHEM> (wherein R<1> and R<2> stand for an aliphatic acyloxy group comprising 2-6 carbon atoms and optionally sub stituted by halogen; or for an aromatic acyloxy group comprising 7-11 carbon atoms) with an amine of the Formula VI <CHEM> (wherein R has the same meaning as stated above) or a salt thereof and subjecting the compound of the general Formula VII <CHEM> thus obtained (wherein R, R<1> and R<2> are as stated above) to hydrolysis after or without isolation and if desired converting the compound of the general Formula I thus obtained into a salt thereof or setting free the same from its salt. The compound of the Formula I is a known antibacterial agent. The advantage of the process of the present invention is that it makes the desired compound of the Formula I available in a simple manner, with a high yield and in a short reaction time.